Related Experiment Video
Updated: Feb 28, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
High-Throughput Sequencing Decodes tsRNA Landscapes: Insights into Cancer Biomarkers and Therapeutic Targets
Miaoyan Pu1,2, Luyu Shi1,2, Chuanlin Shen1,2
1Department of Biochemistry and Molecular Biology, School of Basic Medicine, Chongqing Medical University, Chongqing 400016, China.
None:
Transfer RNA-derived small RNAs (tsRNAs) represent an emerging category of small non-coding RNAs generated through specific cleavage of precursor or mature tRNAs. Increasingly recognized as pivotal players in the pathogenesis of complex malignancies, tsRNAs not only regulate cancer progression but also hold promising clinical potential for cancer diagnosis and treatment. This review highlights recent advances in the application of high-throughput sequencing technologies in the systematic identification of tsRNAs, with a focus on their roles in cancer diagnosis, prognostic assessment, and targeted therapy. Delving into the translational medicine dimensions of tsRNAs may provide novel strategies for molecular diagnosis and therapeutic interventions in oncology.

